Export 10 results:
Author Title Type [ Year(Asc)]
Filters: Author is Shmueli-Blumberg, Dikla  [Clear All Filters]
2022
N. S. Karnik, Marsden, J., McCluskey, C., Boley, R. A., Bradley, K. A., Campbell, C. I., Curtis, M. E., Fiellin, D., Ghitza, U., Hefner, K., Hser, Y. - I., R McHugh, K., McPherson, S. M., Mooney, L. J., Moran, L. M., Murphy, S. M., Schwartz, R. P., Shmueli-Blumberg, D., Shulman, M., Stephens, K. A., Watkins, K. E., Weiss, R. D., and Wu, L. - T., “The Opioid Use Disorder Core Outcomes Set (OUD-COS) for Treatment Research: Findings from a Delphi Consensus Study”, Addiction, vol. 17, no. 9, pp. 2438-2447, 2022.
2021
E. Ertin, Sugavanam, N., Holtyn, A. F., Preston, K. L., Bertz, J. W., Marsch, L. A., McLeman, B., Shmueli-Blumberg, D., Collins, J., King, J. S., McCormack, J., and Ghitza, U. E., “An Examination of the Feasibility of Detecting Cocaine Use Using Smartwatches”, Front Psychiatry, vol. 12, p. 674691, 2021.
J. Harris, Chaney, K., Salazar, D., Ward, A., and Shmueli-Blumberg, D., “Transition from On-Site to Remote Site Initiation Activities”, in Society of Clinical Research Associates (SOCRA), Virtual, 2021.
R. Leslie, Lewis, M., Shmueli-Blumberg, D., and Jelstrom, E., “Transitioning to the Remote Collection of Urine Specimens for Urine Drug Screening During COVID-19”. 2021.
2020
S. M. Lemley, Klausner, J. D., Young, S. D., Stafylis, C., Mulatya, C., Oden, N., Xie, H., Revoredo, L., Shmueli-Blumberg, D., Hichborn, E., McKelle, E., Moran, L., Jacobs, P., and Marsch, L. A., “Comparing Web-Based Platforms for Promoting HIV Self-Testing and Pre-Exposure Prophylaxis Uptake in High-Risk Men Who Have Sex With Men: Protocol for a Longitudinal Cohort Study.”, JMIR Res Protoc, vol. 9, no. 10, p. e20417, 2020.
2019
A. F. Holtyn, Bosworth, E., Marsch, L. A., McLeman, B., Meier, A., Saunders, E. C., Ertin, E., Ullah, M. Azim, Samiei, S. Alan, Hossain, M., Kumar, S., Preston, K. L., Vahabzadeh, M., Shmueli-Blumberg, D., Collins, J., McCormack, J., and Ghitza, U. E., “Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology.”, Contemp Clin Trials Commun, vol. 15, p. 100392, 2019.
2018
J. D. Lee, Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., King, J., Lindblad, R., Liu, D., Matthews, A. G., May, J., K Peavy, M., Ross, S., Salazar, D., Schkolnik, P., Shmueli-Blumberg, D., Stablein, D., Subramaniam, G., and Rotrosen, J., “Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.”, Lancet, vol. 391, no. 10118, pp. 309-318, 2018.
V. Huser and Shmueli-Blumberg, D., “Data sharing platforms for de-identified data from human clinical trials.”, Clin Trials, vol. 15, no. 4, pp. 413-423, 2018.
2016
J. D. Lee, Nunes, E. V., Mpa, P. Novo, Bailey, G. L., Brigham, G. S., Cohen, A. J., Fishman, M., Ling, W., Lindblad, R., Shmueli-Blumberg, D., Stablein, D., May, J., Salazar, D., Liu, D., and Rotrosen, J., “NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale.”, Contemp Clin Trials, vol. 50, pp. 253-64, 2016.
2013
D. Shmueli-Blumberg, Hu, L., Allen, C., Frasketi, M., Wu, L. - T., and VanVeldhuisen, P., “The national drug abuse treatment clinical trials network data share project: website design, usage, challenges, and future directions.”, Clin Trials, vol. 10, no. 6, pp. 977-86, 2013.